athenahealth, Inc (NASDAQ:ATHN) SVP Jonathan D. Porter sold 150 shares of the stock in a transaction that occurred on Saturday, December 29th. The shares were sold at an average price of $134.52, for a total value of $20,178.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Shares of athenahealth, Inc (NASDAQ ATHN) traded down $0.27 during trading on Friday, reaching $135.10. The company’s stock had a trading volume of 316,000 shares, compared to its average volume of 324,233. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67. The stock has a market capitalization of $5,390.00, a price-to-earnings ratio of 175.45, a P/E/G ratio of 3.16 and a beta of 1.58. athenahealth, Inc has a fifty-two week low of $95.01 and a fifty-two week high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, beating the consensus estimate of $0.50 by $0.06. The business had revenue of $304.60 million during the quarter, compared to analyst estimates of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The company’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.60 earnings per share. equities analysts expect that athenahealth, Inc will post 1.22 EPS for the current year.
A number of analysts have recently weighed in on the company. Citigroup assumed coverage on athenahealth in a research note on Thursday. They set a “neutral” rating for the company. BidaskClub raised athenahealth from a “sell” rating to a “hold” rating in a research note on Saturday, December 16th. Deutsche Bank assumed coverage on athenahealth in a research note on Friday, December 8th. They set a “hold” rating and a $145.00 price objective for the company. Cantor Fitzgerald reissued a “hold” rating and set a $120.00 price objective on shares of athenahealth in a research note on Friday, October 27th. Finally, SunTrust Banks reaffirmed a “buy” rating and issued a $156.00 price target on shares of athenahealth in a research note on Wednesday, October 25th. One research analyst has rated the stock with a sell rating, seventeen have issued a hold rating and nine have given a buy rating to the stock. athenahealth has a consensus rating of “Hold” and an average price target of $143.43.
WARNING: “Insider Selling: athenahealth, Inc (ATHN) SVP Sells $20,178.00 in Stock” was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3126955/insider-selling-athenahealth-inc-athn-svp-sells-20178-00-in-stock.html.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.